FDA Confirms Effectiveness of Fidaxomicin

by Kathy Jones on  April 2, 2011 at 9:27 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration confirmed that Optimer Pharmaceuticals' new antibiotic drug, fidaxomicin, is effective in combating a bacterial infection that is the direct cause of diarrhea.
 FDA Confirms Effectiveness of Fidaxomicin
FDA Confirms Effectiveness of Fidaxomicin

While the FDA will conduct a more thorough evaluation of the data available during its advisory panel meeting on Tuesday, the health regulator released documents in which it said that fidaxomicin was able to treat the infection, known as Clostridium difficile.

Share prices of Optimer saw an 11 percent rise to $13.20 before ending the session at $13.13.

Should the drug be given approval by the FDA, then this will be the first from Optimer to reach the US market and analysts predict that the drug would fetch over $200 million in annual sales.




Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive